*	OR T2 T3 T4
R1	Subsumes Arg1:T1 Arg2:T2	
R2	Has_temporal Arg1:T11 Arg2:T12	
R3	AND Arg1:T11 Arg2:T10	
R4	Subsumes Arg1:T14 Arg2:T15	
R5	Has_value Arg1:T13 Arg2:T14	
*	OR T13 T16
*	OR T17 T19
R6	Has_temporal Arg1:T23 Arg2:T24	
*	OR T21 T22
R7	Has_qualifier Arg1:T21 Arg2:T23	
R8	Has_value Arg1:T27 Arg2:T28	
R9	Has_temporal Arg1:T30 Arg2:T31	
R10	Has_qualifier Arg1:T29 Arg2:T30	
*	OR T33 T39 T38 T37 T36 T35 T34 T40
R11	Has_temporal Arg1:T33 Arg2:T32	
*	OR T43 T48 T46 T45 T44 T47
*	OR T53 T54 T52
R12	Has_value Arg1:T54 Arg2:T55	
R13	Has_temporal Arg1:T53 Arg2:T56	
R14	Subsumes Arg1:T1 Arg2:T6	
R15	Has_temporal Arg1:T41 Arg2:T32	
T1	Procedure 20 46	lipid modification therapy
T2	Drug 77 84	statins
T3	Drug 86 94	fibrates
T4	Drug 99 121	bile acid sequestrants
T6	Grammar_Error 95 98	and
T7	Drug 140 148	fish oil
T8	Subjective_judgement 124 240	Subjects taking fish oil or any other supplements, which in the investigator s opinion may interfere with the study.
T9	Post-eligibility 124 240	Subjects taking fish oil or any other supplements, which in the investigator s opinion may interfere with the study.
T10	Condition 256 275	acute liver disease
T11	Condition 286 306	peptic ulcer disease
T12	Temporal 279 285	active
T13	Measurement 332 348	uric acid levels
T14	Value 323 331	elevated
T15	Value 349 370	greater than 10 mg/dL
T16	Condition 374 378	gout
T17	Condition 380 389	Pregnancy
T18	Person 393 398	women
T19	Observation 409 422	breastfeeding
T20	Person 425 431	Female
T21	Drug 448 471	hormonal contraceptives
T22	Procedure 475 502	hormone replacement therapy
T23	Qualifier 561 572	stable dose
T24	Temporal 573 594	for at least 3 months
T26	Grammar_Error 503 518	may be included
T27	Measurement 597 600	BMI
T28	Value 601 615	less than 18.5
T29	Measurement 631 637	weight
T30	Qualifier 643 666	varies greater than 20%
T31	Temporal 667 689	over the past 3 months
T32	Temporal 734 756	for at least six weeks
T33	Drug 812 815	BAS
T34	Drug 817 828	antibiotics
T35	Drug 830 844	anticoagulants
T36	Drug 846 861	anticonvulsants
T37	Drug 863 877	antiarrhythmic
T38	Drug 879 891	Cyclosporine
T39	Drug 893 906	Mycophenolate
T40	Drug 911 920	Synthroid
T41	Grammar_Error 907 910	and
T43	Condition 936 952	chronic diarrhea
T44	Procedure 954 968	gastric bypass
T45	Procedure 972 991	lap band procedures
T46	Procedure 993 1001	ostomies
T47	Condition 1003 1026	bowel motility problems
T48	Condition 1037 1091	conditions that could affect intestinal fat absorption
T49	Undefined_semantics 1037 1091	conditions that could affect intestinal fat absorption
T50	Non-query-able 1094 1187	Subjects initiating new medications or patients on multiple medications may also be excluded.
T51	Condition 1189 1218	Inability to swallow capsules
T52	Condition 1257 1273	type II diabetes
T53	Condition 1247 1253;1265 1273	type I diabetes
T54	Measurement 1277 1282	HbA1c
T55	Value 1283 1300	greater than 6.5%
T56	Temporal 1236 1243	history
T58	Non-query-able 1303 1507	Volunteers may also be excluded, if in the opinion of the study investigators, they have some other condition or disorder that may adversely affect the outcome of the study or the safety of the volunteer.
T59	Subjective_judgement 1303 1507	Volunteers may also be excluded, if in the opinion of the study investigators, they have some other condition or disorder that may adversely affect the outcome of the study or the safety of the volunteer.
T60	Post-eligibility 1303 1507	Volunteers may also be excluded, if in the opinion of the study investigators, they have some other condition or disorder that may adversely affect the outcome of the study or the safety of the volunteer.
